On 4 February 2026, Suzhou Basecare Medical Corporation Limited (stock code: 02170) disclosed its monthly return for the period ending 31 January 2026. The balance of its total authorised share capital remained unchanged at RMB 273,526,000, comprising 82,713,835 H shares, 183,181,817 domestic shares, and 7,630,348 unlisted foreign shares. Each share carries a par value of RMB 1.

No increase or decrease was recorded in the number of issued shares, and there were no share repurchases, share redemptions, or issuance of share options and warrants during January 2026. The public float requirement for the company’s H shares was confirmed to be in compliance at the close of the month, meeting the 25% threshold. There were also no treasury shares on record. According to the disclosure, neither the company nor its subsidiaries repurchased any of the listed securities since 1 January 2026.